Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity

Phytotherapy Research

Volumn 24, Issue SUPPL. 1, 2010, Pages

  Li, Rong ^a   Cai, Li ^a   Xie, Xue Feng ^a   Yang, Feng ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant arthritis; Cytokine; Hesperidin; Synoviocyte

Indexed keywords

COLLAGENASE; HESPERIDIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; IMMUNOMODULATION; MALE; NONHUMAN; PATHOGENESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWELLING; SYNOVIOCYTE; TREATMENT RESPONSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL PROLIFERATION; CELLS, CULTURED; FREUND'S ADJUVANT; HESPERIDIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPLEEN; SYNOVIAL MEMBRANE; THYMUS GLAND; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 75749156173     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2906     Document Type: Article

References (24)

1. Bokarewa M, Lindblad S, Bokarew D, Tarkowski A. 2005. Balance between survivin, a key member of the apoptosis inhibitor family, and its specifi c antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 7: R349-R358.
2. Chen Q, Wei W. 2002. Effects and mechanisms of melatonin on infl ammatory and immune responses of adjuvant arthritis rat. Int Immunopharmacol 2: 1443-1449.
3. Cho ML, Kim WU, Min SY et al. 2002. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. Arthritis Rheum 46: 42-51.
4. Cicala C, Ianaro A, Fiorucci S et al. 2000. NO-naproxen modulates infl ammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 130: 1399-1405.
5. Dayer JM, Feige U, Edwards CK 3rd, Burger D. 2001. Antiinterleukin-1 therapy in rheumatic diseases. Curr Opin Rheumatol 13: 170-176.
6. Gabay C. 2002. Cytokine inhibitors in the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2: 135-149.
7. Galati EM, Monforte MT, Kirjavainen S, Forestieri AM, Trovato A, Tripodo MM. 1994. Biological effects of hesperidin, a citrus fl avonoid. (Note I): antiinfl ammatory and analgesic activity. Farmaco 40: 709-712.
8. Garg A, Garg S, Zaneveld LJ, Singla AK. 2001. Chemistry and pharmacology of the citrus biofl avonoid hesperidin. Phytother Res 15: 655-669.
9. Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF. 1997. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 40: 1073-1084.
10. Jung HJ, Nam JH, Choi J, Lee KT, Park HJ. 2005. Antiinfl ammatory effects of chiisanoside and chiisanogenin obtained from the leaves of Acanthopanax chiisanensis in the carrageenan-and Freund's complete adjuvant-induced rats. J Ethnopharmacol 97: 359-367.
11. Kawaguchi K, Maruyama H, Kometani T, Kumazawa Y. 2006. Suppression of collagen-induced arthritis by oral administration of the citrus fl avonoid hesperidin. Planta Med 72: 477-479.
12. Keystone E, Wherry J, Grint P. 1998. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 24: 629-639.
13. Li R, Li J, Cai L, Hu CM, Zhang L. 2008. Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms. J Pharm Pharmacol 60: 221-228.
14. Newton RC, Decicco CP. 1999. Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha. J Med Chem 42: 2295-2314.
15. Niki Y, Yamada H, Kikuchi T et al. 2004. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol 172: 577-584.
16. Park HJ, Kim MJ, Ha E, Chung JH. 2008. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 15: 147-151.
17. Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R. 1996. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44: 607-614.
18. Rotelli AE, Guardia T, Juarez AO, de la Rocha NE, Pelzer LE. 2003. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 48: 601-606.
19. Simon RA. 2003. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol 24: 189-198.
20. Taylor PC. 2001. Anti-tumor necrosis factor therapies. Curr Opin Rheumatol 13: 164-169.
21. Wilmsen PK, Spada DS, Salvador M. 2005. Antioxidant activity of the fl avonoid hesperidin in chemical and biological systems. J Agric Food Chem 53: 4757-4761.
22. Yeh C-C, Kao S-J, Lin C-C, Wang S-D, Liu C-J, Kao S-T. 2007. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci 80: 1821-1831.
23. Zhang LL, Wei W, Yan SX, Hu XY, Sun WY. 2004. Therapeutic effects of glucosides of Cheanomeles speciosa on collageninduced arthritis in mice. Acta Pharmacol Sin 25: 1495-1501.
24. Zheng YQ, Wei W, Zhu L, Liu JX. 2007. Effects and mechanisms of paeonifl orin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Inflamm Res 56: 182-188.